396 related articles for article (PubMed ID: 18841292)
21. Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies.
Pouplard C; Leroux D; Regina S; Rollin J; Gruel Y
Thromb Haemost; 2010 Jan; 103(1):145-50. PubMed ID: 20062918
[TBL] [Abstract][Full Text] [Related]
22. Performance of 4T score and heparin-platelet factor 4 antibody in the diagnosis of heparin-induced thrombocytopenia (HIT) in cancer.
Wong M; Oo TH; Qiao W; Garg N; Rojas-Hernandez CM
J Thromb Thrombolysis; 2017 Aug; 44(2):261-266. PubMed ID: 28677022
[TBL] [Abstract][Full Text] [Related]
23. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
[TBL] [Abstract][Full Text] [Related]
24. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia.
Zwicker JI; Uhl L; Huang WY; Shaz BH; Bauer KA
J Thromb Haemost; 2004 Dec; 2(12):2133-7. PubMed ID: 15613017
[TBL] [Abstract][Full Text] [Related]
25. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
[TBL] [Abstract][Full Text] [Related]
26. Limited impact of clinician education on reducing inappropriate PF4 testing for heparin-induced thrombocytopenia.
Malalur P; Greenberg C; Lim MY
J Thromb Thrombolysis; 2019 Feb; 47(2):287-291. PubMed ID: 30612329
[TBL] [Abstract][Full Text] [Related]
27. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
Matsuo T; Wanaka K; Asada R
Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
[TBL] [Abstract][Full Text] [Related]
28. Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients.
Berry C; Tcherniantchouk O; Ley EJ; Salim A; Mirocha J; Martin-Stone S; Stolpner D; Margulies DR
J Am Coll Surg; 2011 Jul; 213(1):10-7; discussion 17-8. PubMed ID: 21531584
[TBL] [Abstract][Full Text] [Related]
29. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
Kannan M; Saxena R; Adiguzel C; Fareed J
Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
[TBL] [Abstract][Full Text] [Related]
30. Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia.
Marchetti M; Barelli S; Zermatten MG; Monnin-Respen F; Matthey-Guirao E; Nicolas N; Gomez F; Goodyer M; Gerschheimer C; Alberio L
Blood; 2020 Apr; 135(14):1171-1184. PubMed ID: 31945147
[TBL] [Abstract][Full Text] [Related]
31. Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing?
Beauverd Y; Boehlen F; Tessitore E; Gerstel E; Fontana P; Nendaz M; Perrier A; Reny JL
Platelets; 2015; 26(7):632-7. PubMed ID: 25275932
[TBL] [Abstract][Full Text] [Related]
32. Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia.
Raschke RA; Gallo T; Curry SC; Whiting T; Padilla-Jones A; Warkentin TE; Puri A
J Thromb Haemost; 2017 Aug; 15(8):1640-1645. PubMed ID: 28622439
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia.
Janatpour KA; Gosselin RC; Dager WE; Lee A; Owings JT; Zhou J; Wun T
Am J Clin Pathol; 2007 Mar; 127(3):429-33. PubMed ID: 17276943
[TBL] [Abstract][Full Text] [Related]
34. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
Izban KF; Lietz HW; Hoppensteadt DA; Jeske WP; Fareed J; Bakhos M; Walenga JM
Semin Thromb Hemost; 1999; 25 Suppl 1():51-6. PubMed ID: 10357152
[TBL] [Abstract][Full Text] [Related]
35. Use of a whole-cell ELISA to detect additional antibodies in setting of suspected heparin-induced thrombocytopenia.
Bashover EM; Stefaniuk CM; Harding CV; Maitta RW
Eur J Haematol; 2019 Aug; 103(2):99-106. PubMed ID: 31107976
[TBL] [Abstract][Full Text] [Related]
36. An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia.
Eekels JJM; Althaus K; Bakchoul T; Kroll H; Kiefel V; Nazy I; Lee LS; Sachs U; Warkentin TE; Greinacher A
J Thromb Haemost; 2019 Mar; 17(3):525-531. PubMed ID: 30640980
[TBL] [Abstract][Full Text] [Related]
37. The Role for Optical Density in Heparin-Induced Thrombocytopenia: A Cohort Study.
Chan CM; Woods CJ; Warkentin TE; Sheppard JI; Shorr AF
Chest; 2015 Jul; 148(1):55-61. PubMed ID: 25611568
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit.
Pierce W; Mazur J; Greenberg C; Mueller J; Foster J; Lazarchick J
Ann Clin Lab Sci; 2013; 43(4):429-35. PubMed ID: 24247801
[TBL] [Abstract][Full Text] [Related]
39. A prospective, blinded study of a PF4-dependent assay for HIT diagnosis.
Samuelson Bannow B; Warad DM; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Sharma R; Grill DE; Redman MW; Khalighi PR; Leger RR; Pruthi RK; Chen D; Sabath DE; Aster RH; Garcia DA; Padmanabhan A
Blood; 2021 Feb; 137(8):1082-1089. PubMed ID: 32898858
[TBL] [Abstract][Full Text] [Related]
40. Confirmatory procedure and other maneuvers to assess pathogenicity of platelet factor 4 (PF4)-dependent antibodies--distinguishing "signal" from "noise".
Warkentin TE
Thromb Haemost; 2008 Oct; 100(4):523-4. PubMed ID: 18841271
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
